We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EXPERT: CLINICAL GUIDANCE RETAINS SOME PART 11 RULES
EXPERT: CLINICAL GUIDANCE RETAINS SOME PART 11 RULES
November 5, 2004
Despite appearances to the contrary, it is important to realize the FDA’s latest guidance on computer systems used in clinical trials reaffirms the agency’s intent to enforce the use of 21 CFR Part 11 in certain areas, according to an industry consultant.